Zhejiang Starry Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was CNY 2,445.77 million compared to CNY 2,350.22 million a year ago. Net income was CNY 10.23 million compared to net loss of CNY 49.1 million a year ago.
Basic earnings per share from continuing operations was CNY 0.02 compared to basic loss per share from continuing operations of CNY 0.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to diluted loss per share from continuing operations of CNY 0.12 a year ago.